المؤلفون: Zaaijer, L.H. (Leendert H.), Van Doorn, H.C. (Helena C.), Mourits, M.J. (Marjan), Beurden, M. (Marc) van, Hullu, J.A. (Joanne) de, Adank, M.A. (Muriel), Lonkhuijzen, L. van, Vasen, H. (Hans), Slangen, A.H.L. (Arjen), Gaarenstroom, K.N. (Katja), Zweemer, R.P. (Ronald ), Vencken, P.M.L.H. (Peggy), Seynaeve, C.M. (Caroline), Kriege, M. (Mieke)

المصدر: British Journal of Cancer vol. 115 no. 10, pp. 1174-1178

مصطلحات موضوعية: BRCA mutation, breast cancer, chemotherapy, ovarian cancer, survival

وصف الملف: application/pdf

العلاقة: http://repub.eur.nl/pub/96986Test; urn:hdl:1765/96986

الإتاحة: https://doi.org/10.1038/bjc.2016.333Test
http://repub.eur.nl/pub/96986Test

المؤلفون: Seibold, P. (Petra), Schmezer, P. (Peter), Behrens, T.W. (Timothy), Michailidou, K. (Kyriaki), Bolla, M.K. (Manjeet), Wang, Q. (Qing), Flesch-Janys, D. (Dieter), Nevanlinna, H. (Heli), Fagerholm, R. (Rainer), Aittomäki, K. (Kristiina), Blomqvist, C. (Carl), Margolin, S. (Sara), Mannermaa, A. (Arto), Kataja, V. (Vesa), Kosma, V-M. (Veli-Matti), Hartikainen, J.M. (J.), Lambrechts, D. (Diether), Wildiers, H. (Hans), Kristensen, V. (Vessela), Alnæs, G.G. (Grethe), Nord, S. (Silje), Borresen-Dale, A.-L. (Anne-Lise), Hooning, M.J. (Maartje), Hollestelle, A. (Antoinette), Jager, A. (Agnes), Seynaeve, C.M. (Caroline), Li, J. (Jingmei), Liu, J. (Jianjun), Humphreys, M.K. (Manjeet), Dunning, A.M. (Alison), Rhenius, V. (Valerie), Shah, M. (Mitul), Kabisch, M. (Maria), Torres, D. (Diana), Ulmer, H.U. (Hans), Hamann, U. (Ute), Schildkraut, J.M. (Joellen M.), Purrington, K.S. (Kristen S.), Couch, F.J. (Fergus), Hall, P. (Per), Pharoah, P.D.P. (Paul), Easton, D.F. (Douglas), Schmidt, M.K. (Marjanka), Chang-Claude, J. (Jenny), Popanda, O. (Odilia)

المصدر: BMC Cancer vol. 15 no. 1

مصطلحات موضوعية: Anthracyclines, Chemotherapy, Genetic variation, Radiotherapy, Survival

وصف الملف: application/pdf

العلاقة: http://repub.eur.nl/pub/88975Test; urn:hdl:1765/88975

الإتاحة: https://doi.org/10.1186/s12885-015-1957-7Test
http://repub.eur.nl/pub/88975Test

المؤلفون: Hellemond, I.E.G. van, Smorenburg, C.H., Peer, P.G.M., Swinkels, A.C.P., Seynaeve, C.M., Sangen, M.J.C. van der, Kroep, J.R., Graaf, H. de, Honkoop, A.H., Erdkamp, F.L.G., Berkmortel, F.W.P.J. van den, Roos, W.K. de, Linn, S.C., Imholz, A.L.T., Boer, M. de, Tjan-Heijnen, V.C.G., Dutch Breast Canc Res Grp BOOG

المصدر: Breast Cancer Research and Treatment

مصطلحات موضوعية: Breast cancer, Tamoxifen, Aromatase inhibitor, Bone health, Osteoporosis, Bisphosphonates, Survival, Bone metastases, Distant recurrence-free survival

وصف الملف: application/pdf

العلاقة: https://link.springer.com/article/10.1007/s10549-020-05567-9Test; lumc-id: 111879374; https://hdl.handle.net/1887/3184752Test

الإتاحة: https://doi.org/10.1007/s10549-020-05567-9Test
https://hdl.handle.net/1887/3184752Test

المؤلفون: Hellemond, I.E.G. van, Smorenburg, C.H., Peer, P.G.M., Swinkels, A.C.P., Seynaeve, C.M., Sangen, M.J.C. van der, Kroep, J.R., Graaf, H. de, Honkoop, A.H., Erdkamp, F.L.G., Berkmortel, F.W.P.J. van den, Roos, W.K. de, Linn, S.C., Imholz, A.L.T., Boer, M. de, Tjan-Heijnen, V.C.G., Dutch Breast Canc Res Grp BOOG

المساهمون: Medical Oncology, RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, MUMC+: MA Med Staf Artsass Interne Geneeskunde (9), Interne Geneeskunde, MUMC+: MA Medische Oncologie (9)

المصدر: Breast Cancer Research and Treatment
Breast Cancer Research and Treatment, 180(3), 675-685. Springer New York
Breast Cancer Research and Treatment, 180(3), 675-685. SPRINGER
Breast Cancer Research and Treatment, 180(3), 675-685. Springer, Cham

مصطلحات موضوعية: Cancer Research, Survival, medicine.medical_treatment, Osteoporosis, THERAPY, 0302 clinical medicine, Breast cancer, Bone Density, Bone mineral, RISK, 0303 health sciences, Bone Density Conservation Agents, Diphosphonates, Bisphosphonates, Middle Aged, CHEMOTHERAPY, Prognosis, Clinical Trial, 3. Good health, Women's cancers Radboud Institute for Health Sciences [Radboudumc 17], Survival Rate, Oncology, POSTMENOPAUSAL WOMEN, 030220 oncology & carcinogenesis, ZOLEDRONIC ACID, Female, medicine.drug, musculoskeletal diseases, medicine.medical_specialty, Antineoplastic Agents, Hormonal, Urology, Anastrozole, Breast Neoplasms, MECHANISMS, Bone health, 03 medical and health sciences, All institutes and research themes of the Radboud University Medical Center, SDG 3 - Good Health and Well-being, medicine, Humans, 030304 developmental biology, business.industry, Proportional hazards model, Bone metastases, IN-VITRO, Aromatase inhibitor, Distant recurrence-free survival, Bisphosphonate, medicine.disease, Osteopenia, Bone Diseases, Metabolic, Carcinoma, Lobular, Tamoxifen, Zoledronic acid, CELLS, METASTASIS, Neoplasm Recurrence, Local, business, CLODRONATE, Follow-Up Studies

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f225f2bdc1f8af370c77e7235848558Test
https://hdl.handle.net/1887/3184752Test

المؤلفون: Blok, E.J., Kroep, J.R., Kranenbarg, E.M.K., Duijm-De Carpentier, M., Putter, H., Liefers, G.J., Nortier, J.W.R., Rutgers, E.J.T., Seynaeve, C.M., Velde, C.J.H. van de, IDEAL Study Group, TEAM Study Group

المصدر: European Journal of Cancer

مصطلحات موضوعية: Breast cancer, Extended endocrine therapy, Clinical trial, Compliance, Early treatment discontinuation, Adverse events, Survival, Aromatase inhibitor, Tamoxifen

العلاقة: lumc-id: 44393910; https://hdl.handle.net/1887/95506Test

الإتاحة: https://doi.org/10.1016/j.ejca.2018.03.014Test
https://hdl.handle.net/1887/95506Test